Healthcare101

  Cancer Diagnostics Market in terms of revenue was estimated to be worth $17.2 billion in 2021 and is poised to reach $26.6 billion by 2026, growing at a CAGR of 11.5% from 2021 to 2026 according to a latest report published by MarketsandMarkets™. The growth in this market is attributed to the prevalence of cancer, the increasing number of private diagnostic centers. Moreover, the growth opportunities in emerging markets are expected to provide growth opportunities for players in the cancer diagnostics market during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121 By product , the cancer diagnostics market is segmented into consumables and instruments. In 2020, the instruments segment accounted for the larger share of the cancer diagnostics market. The large share of this segment can be attributed increasing incidence of cancer. Based on the technology , the cancer diagnostics market is segmented into IVD testing, I...

 The report " Cancer Diagnostics Market  by Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), Application (Breast Cancer, Lung Cancer), End User (Hospitals) - Global Forecasts to 2026"  The global cancer diagnostics market size is projected to reach USD 26.6 billion by 2026 from USD 17.2 billion in 2021, at a CAGR of 11.5%. The growth in this market is attributed to the increasing incidence of cancer and increasing number of private diagnostic laboratories. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121 Key Market Players: The major players in the cancer diagnostics market are Danaher Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US.), F. Hoffman-La Roche AG (Switzerland), QIAGEN N.V. (Netherlands), Fujifilm Corporation (Japan), Aglient Technologies (US) and Thermo Fisher Scientific Inc. (US) etc. Cancer Diagno...